Comparative Pharmacology
Head-to-head clinical analysis: NEOMYCIN AND POLYMYXIN B SULFATES BACITRACIN ZINC AND HYDROCORTISONE versus NEOMYCIN POLYMYXIN B SULFATES BACITRACIN ZINC HYDROCORTISONE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: NEOMYCIN AND POLYMYXIN B SULFATES BACITRACIN ZINC AND HYDROCORTISONE versus NEOMYCIN POLYMYXIN B SULFATES BACITRACIN ZINC HYDROCORTISONE.
NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE vs NEOMYCIN & POLYMYXIN B SULFATES & BACITRACIN ZINC & HYDROCORTISONE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Neomycin, polymyxin B, and bacitracin are topical antibiotics that inhibit bacterial protein synthesis (neomycin and bacitracin) or disrupt bacterial cell membrane permeability (polymyxin B). Hydrocortisone is a corticosteroid that suppresses inflammation by inhibiting phospholipase A2, reducing prostaglandin and leukotriene synthesis.
Neomycin, polymyxin B, and bacitracin are antibiotics that inhibit bacterial protein synthesis, disrupt cell membrane integrity, and interfere with cell wall synthesis, respectively. Hydrocortisone is a corticosteroid that suppresses inflammation by inhibiting phospholipase A2, reducing prostaglandin and leukotriene synthesis.
Apply a thin layer to the affected area 2 to 4 times daily. Ophthalmic: 1-2 drops or a small amount (1/2 inch ribbon) into the conjunctival sac every 4 hours, or more frequently in severe infections. Otic: 4 drops into the affected ear(s) 3-4 times daily. Topical: Apply 2-4 times daily. Route: Topical, ophthalmic, otic.
Apply to affected area 3-4 times daily. Not for use in eyes.
None Documented
None Documented
Neomycin: 2-3 hours for absorbed fraction (extensive variability). Polymyxin B: 6-7 hours (prolonged in renal impairment). Bacitracin: 1.5 hours (intramuscular data; topical: negligible). Hydrocortisone: 1.5-2 hours (topical absorption limited).
Neomycin: 2-3h (normal renal); polymyxin B: 4-6h (normal renal), prolonged to 2-3 days in renal impairment; bacitracin: ~1.5h after IM; hydrocortisone: 1.5-2h (plasma). Topical: systemic levels negligible.
Neomycin is primarily excreted unchanged in feces (97%) after oral administration; absorbed fraction is renally excreted. Polymyxin B is mainly eliminated via renal tubular secretion (60-70% unchanged in urine). Bacitracin is predominantly excreted renally (90% unchanged). Hydrocortisone is metabolized hepatically and metabolites are excreted renally. For topical ophthalmic/otic use: negligible systemic absorption; any absorbed drug follows the respective systemic routes.
Neomycin: >90% renal (unchanged) after parenteral; polymyxin B: ~60% renal (unchanged) over 72h; bacitracin: >90% renal (unchanged) after IM; hydrocortisone: hepatic metabolism, metabolites renally eliminated (<1% unchanged). Topical: negligible systemic absorption across intact skin (except bacitracin may be minimally absorbed).
Category A/B
Category A/B
Aminoglycoside Antibiotic
Aminoglycoside Antibiotic